MIR logo

MIRION TECHNOLOGIES INC

MIRNYSE
πŸ† #1571 by market capEarnings Oct 27US Equity
$14.34β–Ό $0.02 (βˆ’0.17%)
Market closed Β· at close
πŸ””
Track MIR
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.2%
7dβ–Ό 12.5%
14dβ–Ό 9.5%
30dβ–Ό 4.9%
ytdβ–Ό 38.8%
1yβ–Ό 38.4%
🏦Market Cap
$3.57B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+15.7%
Healthy
πŸ“ŠGross Margin
48.0%
Healthy
πŸ’΅FCF Margin
13.0%
Healthy
βš–οΈP/S Ratio
3.5x
Fair
Otter Score
56
Weak

Trading Snapshot

Day Range
$14.26 – $14.60
52-Week Range
$14.11 – $30.28
Volume
$1.66B
Avg Volume
$1.16B
Shares Outstanding
249.0M
Next Earnings
Oct 26, 2026

Fundamentals Snapshot

Annual Revenue
$925M
Last Q Revenue
$267M
P/E Ratio
145.5
P/S Ratio
3.5x
EPS (TTM)
$0.09
Dividend Yield
β€”
Dilution (1yr)
+27.4%

Why Investors Own MIR

  • βœ“High-growth profile β€” revenue up -9.8% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 64% gross margin and 19% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

MIR logo

MIRION TECHNOLOGIES INC

MIR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$925Mβ–² +7.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
47.4%β–² +1.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$52Mβ–² +107.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$107Mβ–² +112.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
261.2Mβ–² +27.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$821Mβ–Ό βˆ’$277M YoY
StockOtter Β· stockotter.space

About MIRION TECHNOLOGIES INC

Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
56/100

Analyst Price Target

β“˜
Average Target
$15.72
β–² +9.7% Upside
High Target$17.03
Low Target$11.85
Based on 38 analysts

Latest News & Updates